Literature DB >> 30076746

A rare exonic NRXN3 deletion segregating with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family.

Haiming Yuan1,2, Qingming Wang1, Yanhui Liu1,2, Wei Yang1, Yi He1, James F Gusella3, Jiage Song4, Yiping Shen5,6.   

Abstract

Members of the neurexin gene family, neurexin 1 (NRXN1), neurexin 2 (NRXN2), and neurexin 3 (NRXN3) encode important components of synaptic function implicated in autism and other neurodevelopmental/neuropsychiatric disorders. Loss of function variants have been reported predominantly in NRXN1, with fewer such variants detected in NRXN2 and NRXN3. Evidence for segregating NRNX3 variants has particularly been lacking. Here, we report identification by chromosomal microarray analysis of a rare exonic deletion affecting the NRXN3 alpha isoform in a three-generation Chinese family. The proband, a 7-year-old boy, presented with motor and language delay and met the clinical diagnostic criteria for autism. He also presented with moderate intellectual disability, attention-deficit hyperactivity disorder and facial dysmorphic features. The mother and maternal grandfather, both deletion carriers, presented with variable degrees of language and communication difficulties, as well as neuropsychiatric problems such as schizophrenia and temper tantrums. A compilation of sporadic cases with deletions involving part or all of NRXN3 revealed that 9 of 23 individuals (39%) displayed features of autism. The evidence for cosegregation in our family further supports a role for NRXN3 in autism and neurodevelopmental/neuropsychiatric disorders but demonstrates intrafamily variable expressivity due to this NRXN3 deletion, with schizophrenia and facial dysmorphism being potential novel features of NRXN3 haploinsufficiency.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990NRXN3; autism; intrafamily expressivity; intragenic deletion

Mesh:

Substances:

Year:  2018        PMID: 30076746      PMCID: PMC6445570          DOI: 10.1002/ajmg.b.32673

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  30 in total

1.  Deletion of 11q12.3-11q13.1 in a patient with intellectual disability and childhood facial features resembling Cornelia de Lange syndrome.

Authors:  Martine Isabel Boyle; Cathrine Jespersgaard; Lusine Nazaryan; Kirstine Ravn; Karen Brøndum-Nielsen; Anne-Marie Bisgaard; Zeynep Tümer
Journal:  Gene       Date:  2015-07-08       Impact factor: 3.688

2.  Array-comparative genomic hybridization analysis of a cohort of Saudi patients with epilepsy.

Authors:  Muhammad Faheem; Muhammad I Naseer; Adeel G Chaudhary; Taha A Kumosani; Mahmood Rasool; Hussein A Algahtani; Fehmida Bibi; Mohammad A Kamal; Mohammad H Al-Qahtani
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

3.  A de novo 0.57 Mb microdeletion in chromosome 11q13.1 in a patient with speech problems, autistic traits, dysmorphic features and multiple endocrine neoplasia type 1.

Authors:  Inga Mohrmann; Gabriele Gillessen-Kaesbach; Reiner Siebert; Almuth Caliebe; Yorck Hellenbroich
Journal:  Eur J Med Genet       Date:  2011-04-29       Impact factor: 2.708

4.  A child with deletion (14)(q24.3q32.13) and auditory neuropathy.

Authors:  Kamilla Schlade-Bartusiak; Georgina Macintyre; Janice Zunich; Diane W Cox
Journal:  Am J Med Genet A       Date:  2008-01-01       Impact factor: 2.802

5.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements.

Authors:  Peter Szatmari; Andrew D Paterson; Lonnie Zwaigenbaum; Wendy Roberts; Jessica Brian; Xiao-Qing Liu; John B Vincent; Jennifer L Skaug; Ann P Thompson; Lili Senman; Lars Feuk; Cheng Qian; Susan E Bryson; Marshall B Jones; Christian R Marshall; Stephen W Scherer; Veronica J Vieland; Christopher Bartlett; La Vonne Mangin; Rhinda Goedken; Alberto Segre; Margaret A Pericak-Vance; Michael L Cuccaro; John R Gilbert; Harry H Wright; Ruth K Abramson; Catalina Betancur; Thomas Bourgeron; Christopher Gillberg; Marion Leboyer; Joseph D Buxbaum; Kenneth L Davis; Eric Hollander; Jeremy M Silverman; Joachim Hallmayer; Linda Lotspeich; James S Sutcliffe; Jonathan L Haines; Susan E Folstein; Joseph Piven; Thomas H Wassink; Val Sheffield; Daniel H Geschwind; Maja Bucan; W Ted Brown; Rita M Cantor; John N Constantino; T Conrad Gilliam; Martha Herbert; Clara Lajonchere; David H Ledbetter; Christa Lese-Martin; Janet Miller; Stan Nelson; Carol A Samango-Sprouse; Sarah Spence; Matthew State; Rudolph E Tanzi; Hilary Coon; Geraldine Dawson; Bernie Devlin; Annette Estes; Pamela Flodman; Lambertus Klei; William M McMahon; Nancy Minshew; Jeff Munson; Elena Korvatska; Patricia M Rodier; Gerard D Schellenberg; Moyra Smith; M Anne Spence; Chris Stodgell; Ping Guo Tepper; Ellen M Wijsman; Chang-En Yu; Bernadette Rogé; Carine Mantoulan; Kerstin Wittemeyer; Annemarie Poustka; Bärbel Felder; Sabine M Klauck; Claudia Schuster; Fritz Poustka; Sven Bölte; Sabine Feineis-Matthews; Evelyn Herbrecht; Gabi Schmötzer; John Tsiantis; Katerina Papanikolaou; Elena Maestrini; Elena Bacchelli; Francesca Blasi; Simona Carone; Claudio Toma; Herman Van Engeland; Maretha de Jonge; Chantal Kemner; Frederieke Koop; Frederike Koop; Marjolein Langemeijer; Marjolijn Langemeijer; Channa Hijmans; Channa Hijimans; Wouter G Staal; Gillian Baird; Patrick F Bolton; Michael L Rutter; Emma Weisblatt; Jonathan Green; Catherine Aldred; Julie-Anne Wilkinson; Andrew Pickles; Ann Le Couteur; Tom Berney; Helen McConachie; Anthony J Bailey; Kostas Francis; Gemma Honeyman; Aislinn Hutchinson; Jeremy R Parr; Simon Wallace; Anthony P Monaco; Gabrielle Barnby; Kazuhiro Kobayashi; Janine A Lamb; Ines Sousa; Nuala Sykes; Edwin H Cook; Stephen J Guter; Bennett L Leventhal; Jeff Salt; Catherine Lord; Christina Corsello; Vanessa Hus; Daniel E Weeks; Fred Volkmar; Maïté Tauber; Eric Fombonne; Andy Shih; Kacie J Meyer
Journal:  Nat Genet       Date:  2007-02-18       Impact factor: 38.330

6.  Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.

Authors:  Michael S L Ching; Yiping Shen; Wen-Hann Tan; Shafali S Jeste; Eric M Morrow; Xiaoli Chen; Nahit M Mukaddes; Seung-Yun Yoo; Ellen Hanson; Rachel Hundley; Christina Austin; Ronald E Becker; Gerard T Berry; Katherine Driscoll; Elizabeth C Engle; Sandra Friedman; James F Gusella; Fuki M Hisama; Mira B Irons; Tina Lafiosca; Elaine LeClair; David T Miller; Michael Neessen; Jonathan D Picker; Leonard Rappaport; Cynthia M Rooney; Dean P Sarco; Joan M Stoler; Christopher A Walsh; Robert R Wolff; Ting Zhang; Ramzi H Nasir; Bai-Lin Wu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

7.  Deletion of α-neurexin II results in autism-related behaviors in mice.

Authors:  J Dachtler; J Glasper; R N Cohen; J L Ivorra; D J Swiffen; A J Jackson; M K Harte; R J Rodgers; S J Clapcote
Journal:  Transl Psychiatry       Date:  2014-11-25       Impact factor: 6.222

8.  Interstitial 14q24.3 to q31.3 deletion in a 6-year-old boy with a non-specific dysmorphic phenotype.

Authors:  Mariluce Riegel; Lilia Ma Moreira; Layla D Espirito Santo; Maria Betânia P Toralles; Albert Schinzel
Journal:  Mol Cytogenet       Date:  2014-11-19       Impact factor: 2.009

9.  Disruption of the neurexin 1 gene is associated with schizophrenia.

Authors:  Dan Rujescu; Andres Ingason; Sven Cichon; Olli P H Pietiläinen; Michael R Barnes; Timothea Toulopoulou; Marco Picchioni; Evangelos Vassos; Ulrich Ettinger; Elvira Bramon; Robin Murray; Mirella Ruggeri; Sarah Tosato; Chiara Bonetto; Stacy Steinberg; Engilbert Sigurdsson; Thordur Sigmundsson; Hannes Petursson; Arnaldur Gylfason; Pall I Olason; Gudmundur Hardarsson; Gudrun A Jonsdottir; Omar Gustafsson; Ragnheidur Fossdal; Ina Giegling; Hans-Jürgen Möller; Annette M Hartmann; Per Hoffmann; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamari Tuulio-Henriksson; Srdjan Djurovic; Ingrid Melle; Ole A Andreassen; Thomas Hansen; Thomas Werge; Lambertus A Kiemeney; Barbara Franke; Joris Veltman; Jacobine E Buizer-Voskamp; Chiara Sabatti; Roel A Ophoff; Marcella Rietschel; Markus M Nöthen; Kari Stefansson; Leena Peltonen; David St Clair; Hreinn Stefansson; David A Collier
Journal:  Hum Mol Genet       Date:  2008-10-22       Impact factor: 6.150

10.  Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.

Authors:  Holly A F Stessman; Bo Xiong; Bradley P Coe; Tianyun Wang; Kendra Hoekzema; Michaela Fenckova; Malin Kvarnung; Jennifer Gerdts; Sandy Trinh; Nele Cosemans; Laura Vives; Janice Lin; Tychele N Turner; Gijs Santen; Claudia Ruivenkamp; Marjolein Kriek; Arie van Haeringen; Emmelien Aten; Kathryn Friend; Jan Liebelt; Christopher Barnett; Eric Haan; Marie Shaw; Jozef Gecz; Britt-Marie Anderlid; Ann Nordgren; Anna Lindstrand; Charles Schwartz; R Frank Kooy; Geert Vandeweyer; Celine Helsmoortel; Corrado Romano; Antonino Alberti; Mirella Vinci; Emanuela Avola; Stefania Giusto; Eric Courchesne; Tiziano Pramparo; Karen Pierce; Srinivasa Nalabolu; David G Amaral; Ingrid E Scheffer; Martin B Delatycki; Paul J Lockhart; Fereydoun Hormozdiari; Benjamin Harich; Anna Castells-Nobau; Kun Xia; Hilde Peeters; Magnus Nordenskjöld; Annette Schenck; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2017-02-13       Impact factor: 38.330

View more
  7 in total

1.  Application of Chromosome Microarray Analysis in the Investigation of Developmental Disabilities and Congenital Anomalies: Single Center Experience and Review of NRXN3 and NEDD4L Deletions.

Authors:  Alper Han Çebi; Şule Altıner
Journal:  Mol Syndromol       Date:  2020-10-05

2.  Neurexins cluster Ca2+ channels within the presynaptic active zone.

Authors:  Fujun Luo; Alessandra Sclip; Man Jiang; Thomas C Südhof
Journal:  EMBO J       Date:  2020-03-05       Impact factor: 11.598

3.  Loss of neurexin-1 in Drosophila melanogaster results in altered energy metabolism and increased seizure susceptibility.

Authors:  Kyra A Levy; Eliana D Weisz; Thomas A Jongens
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

4.  Circ_0001367 inhibits glioma proliferation, migration and invasion by sponging miR-431 and thus regulating NRXN3.

Authors:  Liang Liu; Peng Zhang; Xuchen Dong; Haoran Li; Suwen Li; Shan Cheng; Jiaqi Yuan; Xuejun Yang; Zhiyuan Qian; Jun Dong
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

5.  Exploring the Genomic Patterns in Human and Mouse Cerebellums Via Single-Cell Sequencing and Machine Learning Method.

Authors:  ZhanDong Li; Deling Wang; HuiPing Liao; ShiQi Zhang; Wei Guo; Lei Chen; Lin Lu; Tao Huang; Yu-Dong Cai
Journal:  Front Genet       Date:  2022-03-04       Impact factor: 4.599

6.  Reelin cells and sex-dependent synaptopathology in autism following postnatal immune activation.

Authors:  Maryam Ardalan; Tetyana Chumak; Alexandra Quist; Eva Hermans; Ali Hoseinpoor Rafati; Giacomo Gravina; Seyedeh Marziyeh Jabbari Shiadeh; Pernilla Svedin; Setareh Alabaf; Brian Hansen; Gregers Wegener; Lars Westberg; Carina Mallard
Journal:  Br J Pharmacol       Date:  2022-05-23       Impact factor: 9.473

Review 7.  Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions.

Authors:  Bryan Mowry; Jean Giacomotto; Alisha Tromp
Journal:  Mol Psychiatry       Date:  2020-11-15       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.